Sort
50,496 grants matching “lung cancer”
Anti-Tumor Mechanisms and Therapeutic Effects of Vitamin D
$424,249Candace S Johnson · Roswell Park Cancer Institute Corp · R01 · FY2011 · CA
METHYLATION OF THE CALCITONIN GENE IN HUMAN TUMORS
$424,197Johns Hopkins University · R01 · FY2002 · CA
Targeting Glucose Metabolism with HJC0152 for Treating Metastatic Breast Cancer
$424,168Qiang Shen · Lsu Health Sciences Center · R01 · FY2021 · CA
Research Project
$424,126Terrance L. Albrecht · Wayne State University · U54 · FY2013 · CA
Beta Andrenergic Receptor Structure and Desensitization
$424,117Richard B Clark · University Of Texas Hlth Sci Ctr Houston · R01 · FY2009 · GM
Tubulin microtentacles in detached mammary epithelial cells
$424,018Stuart S Martin · University Of Maryland Baltimore · R01 · FY2023 · CA
Tubulin microtentacles in detached mammary epithelial cells
$424,018Stuart S Martin · University Of Maryland Baltimore · R01 · FY2025 · CA
Defining the role of Hippo signaling in airway injury repair and remodeling
$423,899Jayaraj Rajagopal · Massachusetts General Hospital · R01 · FY2016 · HL
Defining the role of Hippo signaling in airway injury repair and remodeling
$423,899Jayaraj Rajagopal · Massachusetts General Hospital · R01 · FY2017 · HL
Functional Determinants of Metastatic Dormancy
$423,844Julio A Aguirre-Ghiso · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA
Functional Determinants of Metastatic Dormancy
$423,844Julio A Aguirre-Ghiso · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · CA
Nanoscale Coordination Polymers of Cyclic-di-nucleotides and Peptide Antigens for Effective Therapy of Metastatic Colorectal Cancer
$423,829Ralph R Weichselbaum · University Of Chicago · R01 · FY2024 · CA
A Role for KSHV in the Pathogenesis of Malignancies
$423,804Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
Transmembrane Proteins Involved in Human Tumor Expansion
$423,800James P Quigley · Scripps Research Institute, The · R01 · FY2018 · CA
Design, Synthesis, and Evaluation of Lactate Dehydrogenase Inhibitors
$423,781Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2014 · GM
HIFU-enhanced tumor vaccines
$423,775Chandan Guha · Albert Einstein College Of Medicine · R01 · FY2009 · EB
A cost-effective radiation treatment delivery system for the low- and middle-income countries
$423,767Eric C Ford · University Of Washington · UG3 · FY2017 · CA
HLTF gene silencing: a novel determinant of sensitivity to autophagy inhibition
$423,754Ravi K Amaravadi · University Of Pennsylvania · R01 · FY2013 · CA
Functional Image and Molecular Marker to Individualize Adaptive Radiation Dose Es
$423,750Feng-Ming P. Kong · University Of Michigan At Ann Arbor · R01 · FY2010 · CA
Identifying immune correlates of disease severity and novel immune drivers of pathogenicity to target in patients with COVID-19
$423,750Ramon E Parsons · Icahn School Of Medicine At Mount Sinai · P30 · FY2020 · CA
EXPLORING THE LINK BETWEEN LUNG CANCER LINEAGE HETEROGENEITY AND MICROENVIRONMENT
$423,750Icahn School Of Medicine At Mount Sinai · · FY2019 · Department of the Army
Serum Antibody Profiling with a Carbohydrate Microarray
$423,701Jeff Gildersleeve · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Personalized Risk-AdaptIve Surveillance (PRAISE) - Implications of Algorithmic Bias
$423,669Aasthaa Bansal · University Of Washington · R37 · FY2024 · CA
Clinical production of viral vectors for cancer gene therapy
$423,627Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Image guided X-ray irradiator for biomedical research
$423,555Charles A. Pelizzari · University Of Chicago · S10 · FY2010 · RR